Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8819 |
High Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8561 |
High Similarity |
NPD3027 |
Phase 3 |
0.8374 |
Intermediate Similarity |
NPD228 |
Approved |
0.8268 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.824 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8231 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8134 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8054 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7971 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7971 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7956 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7947 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7935 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD2801 |
Approved |
0.792 |
Intermediate Similarity |
NPD3022 |
Approved |
0.792 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7914 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7863 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7842 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7817 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7808 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.777 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7736 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7727 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7724 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7722 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7698 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7687 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7673 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7664 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7647 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7632 |
Intermediate Similarity |
NPD37 |
Approved |
0.7626 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7616 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7613 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7612 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7603 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7597 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7584 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7557 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7554 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7534 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7532 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7519 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7482 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD943 |
Approved |
0.7465 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7448 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7445 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7426 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7426 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD447 |
Suspended |
0.741 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7405 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7397 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7397 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7386 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7379 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7378 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7372 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7361 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7343 |
Intermediate Similarity |
NPD826 |
Approved |
0.7343 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7343 |
Intermediate Similarity |
NPD825 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7319 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7285 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7279 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7279 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7266 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7246 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7236 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7236 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7234 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD5494 |
Approved |
0.723 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7214 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7211 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7209 |
Intermediate Similarity |
NPD290 |
Approved |
0.7206 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7203 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7203 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7203 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7203 |
Intermediate Similarity |
NPD3145 |
Approved |
0.72 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7197 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7188 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7181 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7181 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7172 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7171 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7171 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7164 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7163 |
Intermediate Similarity |
NPD257 |
Approved |
0.7163 |
Intermediate Similarity |
NPD258 |
Approved |
0.7154 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7154 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7154 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7153 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7153 |
Intermediate Similarity |
NPD17 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7133 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7132 |
Intermediate Similarity |
NPD968 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7105 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7099 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7099 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7095 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7095 |
Intermediate Similarity |
NPD2239 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5712 |
Approved |
0.7095 |
Intermediate Similarity |
NPD9570 |
Approved |
0.7095 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD2240 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1501 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD1203 |
Approved |
0.709 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7089 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7087 |
Intermediate Similarity |
NPD291 |
Approved |
0.7086 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7078 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.7077 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7075 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7075 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7075 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7071 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7071 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD2976 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7059
|
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |